Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PDF Solutions
PDFS
$2.14B
| $471K | ﹤0.01% |
14,544
-1,161
| -7% | -$44.5K |
|
2752
Amylyx Pharmaceuticals
AMLX
$2.43B
| $471K | ﹤0.01% |
25,699
-52,285
| -67% | -$1.11M |
|
2753
Alto Ingredients
ALTO
$410M
| $470K | ﹤0.01% |
106,345
+72,092
| +210% | +$279K |
|
2754
Southern Missouri Bancorp
SMBC
$874M
| $469K | ﹤0.01% |
12,133
-192
| -2% | -$8.21K |
|
2755
Pitney Bowes
PBI
$2.52B
| $469K | ﹤0.01% |
155,396
+4,293
| +3% | +$14.7K |
|
2756
Altimmune
ALT
$597M
| $469K | ﹤0.01% |
180,409
+69,014
| +62% | +$198K |
|
2757
Forrester Research
FORR
$228M
| $468K | ﹤0.01% |
16,191
+2,942
| +22% | +$90.5K |
|
|
UHT
2758
Universal Health Realty Income Trust
UHT
$587M
| $467K | ﹤0.01% |
11,559
-27,971
| -71% | -$1.3M |
|
2759
Mid Penn Bancorp
MPB
$971M
| $466K | ﹤0.01% |
23,154
+3,548
| +18% | +$78.6K |
|
|
MCW
2760
DELISTED
Mister Car Wash
MCW
| $466K | ﹤0.01% |
84,548
+26,915
| +47% | +$205K |
|
2761
Energy Recovery
ERII
$470M
| $465K | ﹤0.01% |
21,940
+1,671
| +8% | +$44.6K |
|
2762
NRC Health Common Stock
NRC
$434M
| $465K | ﹤0.01% |
10,484
-175
| -2% | -$7.64K |
|
2763
AMERISAFE
AMSF
$557M
| $464K | ﹤0.01% |
9,261
-1,187
| -11% | -$62.3K |
|
2764
Fiverr
FVRR
$347M
| $463K | ﹤0.01% |
18,923
+384
| +2% | +$10.8K |
|
|
CMRC
2765
Commerce.com Inc Series 1
CMRC
$269M
| $461K | ﹤0.01% |
46,748
-5,469
| -10% | -$57K |
|
|
FFIC
2766
DELISTED
Flushing Financial
FFIC
| $457K | ﹤0.01% |
34,782
-9,149
| -21% | -$128K |
|
2767
Sturm, Ruger & Co
RGR
$625M
| $456K | ﹤0.01% |
8,747
-591
| -6% | -$31K |
|
2768
Phibro Animal Health
PAHC
$1.48B
| $455K | ﹤0.01% |
35,638
+13,332
| +60% | +$189K |
|
2769
WisdomTree
WT
$3.42B
| $452K | ﹤0.01% |
64,542
+2,500
| +4% | +$17.5K |
|
|
PETQ
2770
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $451K | ﹤0.01% |
22,917
+8,173
| +55% | +$146K |
|
2771
Aehr Test Systems
AEHR
$3.58B
| $451K | ﹤0.01% |
9,875
-1,088
| -10% | -$50.4K |
|
2772
Skyward Specialty Insurance
SKWD
$2.5B
| $451K | ﹤0.01% |
16,494
+11,953
| +263% | +$298K |
|
2773
Healthcare Services Group
HCSG
$1.59B
| $450K | ﹤0.01% |
43,139
+1,551
| +4% | +$19.3K |
|
2774
Primoris Services
PRIM
$4.93B
| $446K | ﹤0.01% |
13,632
+2,062
| +18% | +$67.4K |
|
2775
Orion
OEC
$376M
| $445K | ﹤0.01% |
20,892
-3,313
| -14% | -$72.3K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.